Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes (Q39874482)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 March 2009
edit
Language Label Description Also known as
English
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
scientific article published on 10 March 2009

    Statements

    Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes (English)
    1 reference
    0 references
    C Alfaro
    1 reference
    N Suarez
    1 reference
    A Gonzalez
    1 reference
    S Solano
    1 reference
    L Erro
    1 reference
    J Dubrot
    1 reference
    A Palazon
    1 reference
    S Hervas-Stubbs
    1 reference
    A Gurpide
    1 reference
    J M Lopez-Picazo
    1 reference
    E Grande-Pulido
    1 reference
    I Melero
    1 reference
    J L Perez-Gracia
    1 reference
    10 March 2009
    1 reference
    100
    1 reference
    1111-1119
    1 reference
    7
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit